PCV1 virus DNA found in GSK's Rotarix vaccine
GSK has confirmed that material from the PCV1 virus has been detected in Rotarix and, although there is no evidence of a safety risk, the FDA has recommended use is temporarily suspended.
GSK has confirmed that material from the PCV1 virus has been detected in Rotarix and, although there is no evidence of a safety risk, the FDA has recommended use is temporarily suspended.
Cambrex has acquired IEP GmbH to expand its biocatalytic process development services and the range of enzymes it can offer to pharma clients.
The IPEA's issuance of good manufacturing practice (GMP) “certification” is mark of manufacturing quality, says US specialty chemicals supplier W R Grace & Co.
Industrial glass maker Schott ended a “rather difficult” fiscal 2009 with a loss but says rise in drug packaging sales will help drive double-digit earnings growth in current financial year.
IRL and Epichem have entered into a strategic alliance to provide the Australasian pharma market with services from drug discovery through to cGMP production.
Outsourcing-Pharma presents its latest round up of movements in the pharma sector, including appointments at Quintiles, PharmaNet, IGI Laboratories and Sentrx.